These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2845175)

  • 1. Clinical application of a new in vitro bleeding time device on surgical patients.
    Tsujinaka T; Itoh T; Uemura Y; Sakon M; Kambayashi J; Mori T
    Jpn J Surg; 1988 Jul; 18(4):430-7. PubMed ID: 2845175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DN.9693, a phosphodiesterase inhibitor, compared with prostaglandin E1 and prostacyclin in four platelet "function" tests.
    O'Brien JR; Etherington MD; Salmon GP
    Thromb Res; 1988 Apr; 50(1):237-41. PubMed ID: 2840751
    [No Abstract]   [Full Text] [Related]  

  • 3. Study for determination of the optimal cessation period of therapy with anti-platelet agents prior to invasive endoscopic procedures.
    Komatsu T; Tamai Y; Takami H; Yamagata K; Fukuda S; Munakata A
    J Gastroenterol; 2005 Jul; 40(7):698-707. PubMed ID: 16082586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled trial of desmopressin in liver cirrhosis and other conditions associated with a prolonged bleeding time.
    Mannucci PM; Vicente V; Vianello L; Cattaneo M; Alberca I; Coccato MP; Faioni E; Mari D
    Blood; 1986 Apr; 67(4):1148-53. PubMed ID: 3513867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of acetylsalicylic acid, ticlopidine and cilostazol on primary hemostasis using a quantitative bleeding time test apparatus.
    Tamai Y; Takami H; Nakahata R; Ono F; Munakata A
    Haemostasis; 1999; 29(5):269-76. PubMed ID: 10754379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Exploring the effect of aspirin on primary hemostasis through bleeding time. Study of 16 volunteers].
    Gargouri J; Mnif H; Sellami S; Rekik H
    Tunis Med; 2004 Feb; 82(2):219-22. PubMed ID: 15185599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphodiesterase inhibitors as antiplatelet agents in vascular surgery.
    Kambayashi J; Watase M; Kawasaki T; Shiba E; Sakon M; Mori T; Isaka Y; Kimura K; Kamada T
    Adv Second Messenger Phosphoprotein Res; 1992; 25():383-93. PubMed ID: 1313269
    [No Abstract]   [Full Text] [Related]  

  • 8. DN 9693: a phosphodiesterase inhibitor with a platelet membrane effect.
    Jackson C; Ball J; Peel J; Lawry J; Greaves M; Preston FE
    Thromb Haemost; 1989 Apr; 61(2):266-9. PubMed ID: 2546286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnitude and time course of impaired primary haemostasis after stopping chronic low and medium dose aspirin in healthy volunteers.
    Sonksen JR; Kong KL; Holder R
    Br J Anaesth; 1999 Mar; 82(3):360-5. PubMed ID: 10434816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of aspirin induced changes in bleeding time, platelet aggregation, and Sonoclot coagulation analysis in humans.
    Samra SK; Harrison RL; Bee DE; Valero V
    Ann Clin Lab Sci; 1991; 21(5):315-27. PubMed ID: 1952780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized clinical trial comparing point-of-care platelet function assays and bleeding time in healthy subjects treated with aspirin or clopidogrel.
    Chen F; Maridakis V; O'neill EA; Beals C; Radziszewski W; de Lepeleire I; Van Dyck K; Depré M; Bolognese JA; de Hoon J; Jacquemin M
    Platelets; 2012; 23(4):249-58. PubMed ID: 21919555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between prostaglandin E2 and inhibitors of platelet aggregation which act through cyclic AMP.
    Gray SJ; Heptinstall S
    Eur J Pharmacol; 1991 Feb; 194(1):63-70. PubMed ID: 1647965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic effects of TAK-029, a novel GPIIb/IIIa antagonist, in guinea pigs: comparative studies with ticlopidine, clopidogrel, aspirin, prostaglandin E1 and argatroban.
    Kawamura M; Imura Y; Moriya N; Kita S; Fukushi H; Sugihara H; Nishikawa K; Terashita Z
    J Pharmacol Exp Ther; 1996 Apr; 277(1):502-10. PubMed ID: 8613960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The skin bleeding time test as a predictor of brain bleeding time in a rat model.
    MacDonald JD; Remington BJ; Rodgers GM
    Thromb Res; 1994 Dec; 76(6):535-40. PubMed ID: 7900100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 7-Bromo-1,5-dihydro-3,6-dimethylimidazo[2,1-b]quinazolin-2(3H)- one (Ro 15-2041), a potent antithrombotic agent that selectively inhibits platelet cyclic AMP-phosphodiesterase.
    Muggli R; Tschopp TB; Mittelholzer E; Baumgartner HR
    J Pharmacol Exp Ther; 1985 Oct; 235(1):212-9. PubMed ID: 2995647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demonstration of functional compartments of cyclic AMP in rat platelets by the use of phosphodiesterase inhibitors.
    Ashida S; Sakuma K
    Adv Second Messenger Phosphoprotein Res; 1992; 25():229-39. PubMed ID: 1313259
    [No Abstract]   [Full Text] [Related]  

  • 18. Clopidogrel inhibition of stent, graft, and vascular thrombogenesis with antithrombotic enhancement by aspirin in nonhuman primates.
    Harker LA; Marzec UM; Kelly AB; Chronos NR; Sundell IB; Hanson SR; Herbert JM
    Circulation; 1998 Dec; 98(22):2461-9. PubMed ID: 9832493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Haemostasis time", a modified bleeding time test and its comparison with the Duke and Ivy/template bleeding times. I. Normal values, application in thrombocytopenic patients and evaluation of heparin and aspirin effects.
    Janzarik H; Remy S; Morell S; Pabst W
    Blut; 1986 Jun; 52(6):345-56. PubMed ID: 3719109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anagrelide: a potent and selective inhibitor of platelet cyclic AMP phosphodiesterase enzyme activity.
    Gillespie E
    Biochem Pharmacol; 1988 Jul; 37(14):2866-8. PubMed ID: 2456068
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.